Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

14 Nov 2018 07:42

RNS Number : 3016H
Falanx Group Limited
14 November 2018
 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Falanx Group Limited

("Falanx" or "the Company")

Issue of Equity

 

Falanx Group (AIM: FLX) ("Falanx" or "the Group" or "the Company" announces that on 14th of November 2018, the Company has issued 138,500,000 new ordinary shares of no par value in the capital of the Company ("Ordinary Shares") due to institutional demand ("the Subscription"). The Subscription has raised gross proceeds of £4,155,000 at a price of 3 pence per share.

 

This Subscription is almost entirely comprised of new institutional investors, including Miton Asset Management and Amati Global Investors. The proceeds will enable the Company to:

 

· Invest in delivery capabilities around a larger scale deployment into the SolarWinds customer base, by financing the additional sales, marketing, operations staff and required corporate infrastructure. This will include further technology investment, application rollout and Security Operations Centre expansion, to seamlessly handle much larger volumes;

 

· Address and accelerate incremental sales opportunities across the whole Group;

 

· Increase customer and partner confidence due to a significantly strengthened balance sheet;

 

· Provide (through non EIS/VCT monies) funding for opportunistic but earnings enhancing acquisitions.

 

Building on the progress detailed in the interim results for the six months ended 30 September 2018 released earlier today, the proceeds of the Subscription will allow the Company to undertake certain incremental initiatives of both a capital and operational nature. This will assist the business to drive and accelerate incremental returns over future periods and these are now expected to be greater than those originally envisaged.

 

Save for the routine issuance of shares under option and for warrant agreements for the incentivisation of staff, the Company does not expect to be issuing further equity save for a major incremental value creating project or earnings enhancing acquisitions.

 

Mike Read, Chairman and Chief Executive, commented;

 

"I am delighted the strength of our business and our future opportunities has attracted several new institutional investors, who have provided Falanx with a strong capital base for the future. This new support will enable the Group to grow in a rapidly expanding market, creating increased value for all our shareholders"

 

Total Voting Rights and Admission

 

Application will be made to the London Stock Exchange for the Subscription Shares to be admitted to trading on AIM ("Admission"). The Subscription Shares will rank pari passu in all respects with the existing ordinary shares, including the right to receive all dividends and other distributions declared, made or paid in respect of the Ordinary Shares following Admission. It is expected that Admission will become effective, and that dealings on AIM will commence on or around, 8.00 a.m. on 20 November 2018.

 

Following Admission, the Company will have 400,401,186 Ordinary Shares in issue. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares with voting rights in the Company will be 400,401,186. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules sourcebook.

 

 

Enquiries:

 

 

Falanx Group Limited

Mike Read, Chief Executive Officer

 

www.falanx.com

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis / James Keeshan

+44 (0) 203 368 3551

 

 

 

 

 

Turner Pope Investments (TPI) Ltd

Broker

Ben Turner / James Pope

 

IFC Advisory Ltd

Financial PR & IR

Graham Herring

Miles Nolan

Zach Cohen

+44 (0) 203 621 4120

 

 

 

+44 (0) 203 934 6630

 

     

 

About Falanx

Falanx Group Limited, is a global intelligence and cyber defence provider working with blue chip and government clients. It operates the MidGARD cyber monitoring platform for corporate and governmental customers which utilises a combination of proprietary and third-party processes and technologies. For more information: http://www.falanx.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEDZLBFVFFXFBK
Date   Source Headline
4th May 201712:02 pmRNSDirector / PDMR Shareholding
4th May 201712:02 pmRNSResults of the Placing and Total Voting Rights
4th May 20177:02 amRNSProposed Placing to raise up to £2 million
4th May 20177:00 amRNSTrading Update
18th Apr 201712:15 pmRNSChange of Website Address
28th Mar 20177:00 amRNSProprietary Platform and Partnership Agreements
8th Mar 20177:00 amRNSAppointment of Chief Finance Officer
13th Feb 20177:00 amRNSNew Business Unit - Falanx Cyber Technologies
30th Jan 20177:02 amRNSDirectorate Change
30th Jan 20177:01 amRNSOperational Update
30th Jan 20177:00 amRNSChange of Adviser
25th Jan 20177:00 amRNSDirector/PDMR Shareholding
11th Jan 20179:00 amRNSIssue of Equity
20th Dec 20161:49 pmRNSDirector/PDMR Shareholding
15th Dec 20167:00 amRNSAGM Statement
25th Nov 20165:11 pmRNSIssue of Equity
16th Nov 20165:55 pmRNSNotice of AGM
9th Nov 20163:20 pmRNSAdditional Listing
1st Nov 20167:01 amRNSInterim Results
1st Nov 20167:00 amRNSDirectorate Change
26th Oct 20169:53 amRNSHolding(s) in Company
19th Oct 201611:07 amRNSHolding(s) in Company
17th Oct 20167:00 amRNSDirectorate Change, Trading Update, Notice of Rsts
3rd Oct 20167:00 amRNSPlacing and Early Redemption of Loan Note
18th Jul 20167:00 amRNSPreliminary Results
20th Jun 20167:00 amRNSDirectorate Change
11th May 201610:14 amRNSIssue of Equity and Directors' Dealings
11th May 20167:00 amRNSTrading Update and New Cyber Security Contract Win
5th May 20167:00 amRNSAcquisition, Placing and issue of Loan Notes
21st Mar 20167:00 amRNSContract win
2nd Feb 20167:00 amRNSAppointment of Non-Executive Chairman
23rd Dec 20153:15 pmRNSDirector Dealing
21st Dec 20157:00 amRNSSignificant contract win
9th Nov 20157:00 amRNSInterim Results
6th Nov 20158:49 amRNSDirectorate Change
26th Oct 20157:00 amRNSNotice of Results
15th Oct 20157:00 amRNSChange of Adviser
24th Sep 20157:00 amRNSOperational Update
15th Jul 20157:00 amRNSPreliminary Results
6th Jul 201510:21 amRNSNotice of Results
21st May 20152:33 pmRNSHolding(s) in Company
18th May 201510:56 amRNSHolding(s) in Company
15th May 201511:11 amRNSHolding(s) in Company
8th May 20157:00 amRNS£2.64 million placing
18th Mar 20157:00 amRNSFalanx Cyber Update
2nd Mar 20157:00 amRNSCyber Insurance Joint Venture
2nd Feb 20157:00 amRNSUK Government Framework Agreement
31st Dec 20147:00 amRNSTotal Voting Rights
22nd Dec 20147:00 amRNSInterim Results
1st Dec 20147:00 amRNSExercise of Warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.